These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8241842)

  • 1. Tissue typing, heart and heart-lung transplantation.
    Joysey VC
    Br J Biomed Sci; 1993 Sep; 50(3):272-6. PubMed ID: 8241842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of HLA matching for lung transplantation.
    McGee C; Fox MD; Loyd JE
    Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat heart-lung transplantation outcome in the United States.
    Shuhaiber JH; Kim JB; Gibbons RD
    J Heart Lung Transplant; 2008 Oct; 27(10):1122-7. PubMed ID: 18926404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume.
    Suh KS; Kim SB; Chang SH; Kim SH; Minn KW; Park MH; Han KS; Lee KU
    Liver Transpl; 2002 Dec; 8(12):1109-13. PubMed ID: 12474148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA-matching effect in different cohorts of kidney transplant recipients.
    Terasaki PI
    Clin Transpl; 2000; ():497-514. PubMed ID: 11512361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cytomegalovirus match on survival after cardiac and lung transplantation.
    Bonatti H; Tabarelli W; Ruttmann E; Kafka R; Larcher C; Höfer D; Klaus A; Laufer G; Geltner C; Margreiter R; Müller L; Antretter H
    Am Surg; 2004 Aug; 70(8):710-4. PubMed ID: 15328806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
    Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; De Meester J; Doxiadis II; Claas FH
    Transplantation; 2000 Jul; 70(1):157-61. PubMed ID: 10919594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.